On January 27th, Max India Ltd (Ticker: MAX IN, INR 498 per share, Market Capitalization: INR 132,780 million—USD 2,164 million based on an exchange rate of USD 1 = INR 61.35) announced its intention to split in three publically traded corporations, with shareholders retaining their proportionate equity interest in all of the demerged entities. The parent corporation will be renamed Max Financial Services Limited and will comprise the company’s life insurance business—Max India’s dominant segment. The second company will operate in the healthcare sector, and will be named Max India Limited. Its subsidiaries will include Max Healthcare (healthcare services), Max Bupa Health Insurance (health insurance) and Antara Senior Living (senior living communities). Max India’s specialty packaging films segment will be demerged into a Max Ventures and Industries Limited.
Shareholders will receive one new Max India share and 0.2 Max Ventures and Industries shares for each Max India share owned. The transaction is subject to shareholder, creditor and regulatory approvals and is expected to be completed within the next six to nine months.
Max India is an owner-operated company, with Chairman Analjit Singh controlling approximately 40 percent of shares outstanding. For the six months ending on September 30th, 2014—the company’s fiscal year ends on March 31st—Max India’s consolidated revenue, including investment gains on the insurance portfolios, were INR 69.7 billion compared to INR 45.7 billion for the year ago period. EBITDA and pre-tax profit stood at INR 3.3 billion (30 percent year-on-year increase) and INR 1.9 billion (43 percent year-on-year increase), respectively.
Max India’s flagship business, generating more than 80 percent of consolidated revenue, is life insurance. The company is active in the sector through its 72 percent holding in Max Life, a joint venture with Japan’s MS & AD Insurance Group Holding Inc (8725 JP)—the successor of Mitsui Sumitomo Insurance Company. For the six months ending on September 30th, 2014, Max Life generated gross written premium income of INR 33.9 billion, a 13 percent year-on-year increase.
Max Ventures and Industries will consist of the wholly-owned subsidiary Max Specialty Films. The company produces packaging films used in tobacco packaging and beverage labels, among others. For the first half of the 2015 fiscal year, the company generated INR 3.9 billion in revenue (10 percent year-on-year increase) and INR 380 million in EBITDA (36 percent year-on-year increase). The company will be the smallest of the post-demerger entities. It will also have just INR 100 million in cash—just over USD 1.5 million.
The healthcare-focused company will comprise the company’s interest in Max Healthcare, Max Bupa Health Insurance and Antara Senior Living. Antara Senior Living developed its first senior living community in 2013. Max Healthcare owns and operates 12 hospitals in North India and is 46 percent owned by Max India. The parent company’s ownership amounted to almost 70 percent until November 2014, when its partner, South African Life Healthcare Group Holdings Ltd (LHC SJ) announced that it will acquire a 13 percent stake from Max India and invest INR 3.8 billion directly in the operating company. Lastly, Max India offers health insurance services through its 74 percent owned subsidiary, Max Bupa Health Insurance. The remaining 26 percent is owned by Britain’s Bupa Finance Plc. Following the recent decree by Indian Prime Minister Narendra Modi that increases the foreign direct investment limit in insurance companies to 49 percent from 26 percent, Bupa Finance announced its plan to raise its interest in the Indian health insurance firm to the maximum allowable level.
The liberalization of the healthcare market is one of the most important considerations with regard to Max India’s split: the company foresees a unique opportunity to expand. Thus, the new Max India will benefit from increased management focus as well as substantially higher foreign investment that will allow for rapid growth. Management’s intention and focus on expansion is further strengthened by the fact that the healthcare spinco will receive more than INR 4 billion out of the company’s estimated INR 6 billion in cash1. Thus, despite the corporation’s limited revenue—with fiscal half year sales at Max Healthcare of INR 8.5 billion and INR 1.6 billion in gross written premium income at Max Bupa Health Insurance2—new Max India could start trading at very high profit-based multiples3, care of its growth potential and substantial cash balance that amounts to approximately a quarter of its yearly sales.